Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-02-24 @ 2:08 PM
Study NCT ID:
NCT01113957
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2010-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M10-757
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None